BackgroundMost Chlamydia trachomatis (CT) infections are asymptomatic. The infection can persist and lead to severe sequelae. Therefore, screening for CT can primarily prevent serious sequelae.AimTo systematically evaluate CT screening from the perspective of health economics, summarize previous findings from different target populations, and make practical recommendations for developing local CT screening strategies.MethodsPubMed, Web of Science, Embase, Cochran Library, and National Health Service Economic Evaluation Database (Ovid) were searched from January 1, 2000, to March 4, 2023. Studies reporting the cost-effectiveness, cost-benefit, or cost-utility of CT screening were eligible to be included. A narrative synthesis was used to ana...
Objective. To estimate the cost effectiveness of Chlamydia trachomatis (CT) screening of young women...
OBJECTIVE: To assess the cost-effectiveness of pharmacotherapy for male partners in screening women ...
BACKGROUND: The majority of Chlamydia trachomatis infections in women are asymptomatic, but may give...
OBJECTIVE: To review systematically and critically, evidence used to derive estimates of costs and c...
Objective The aims of this study were to determine cost effectiveness of screening for Chlamydia tra...
Objectives: To evaluate the cost effectiveness of a systematic screening programme for asymptomatic ...
OBJECTIVES: To investigate epidemiological, social, diagnostic and economic aspects of chlamydia scr...
Background: Models commonly used for the economic assessment of chamydial screening programs do not ...
OBJECTIVE: Screening for Chlamydia trachomatis in the lower genital tract may contribute to the prev...
Chlamydia trachomatis is the most common, curable, sexually transmitted disease in many Western coun...
OBJECTIVE: To investigate the cost effectiveness of screening for Chlamydia trachomatis compared wit...
Objective. To estimate cost effectiveness of opportunistic screening for Chlamydia trachomatis (CT) ...
To estimate the cost-effectiveness of a systematic one-off Chlamydia trachomatis (CT) screening prog...
Chlamydia trachomatis is the most prevalent sexually transmitted bacteria in the US and results in r...
Objective. To estimate the cost effectiveness of Chlamydia trachomatis (CT) screening of young women...
OBJECTIVE: To assess the cost-effectiveness of pharmacotherapy for male partners in screening women ...
BACKGROUND: The majority of Chlamydia trachomatis infections in women are asymptomatic, but may give...
OBJECTIVE: To review systematically and critically, evidence used to derive estimates of costs and c...
Objective The aims of this study were to determine cost effectiveness of screening for Chlamydia tra...
Objectives: To evaluate the cost effectiveness of a systematic screening programme for asymptomatic ...
OBJECTIVES: To investigate epidemiological, social, diagnostic and economic aspects of chlamydia scr...
Background: Models commonly used for the economic assessment of chamydial screening programs do not ...
OBJECTIVE: Screening for Chlamydia trachomatis in the lower genital tract may contribute to the prev...
Chlamydia trachomatis is the most common, curable, sexually transmitted disease in many Western coun...
OBJECTIVE: To investigate the cost effectiveness of screening for Chlamydia trachomatis compared wit...
Objective. To estimate cost effectiveness of opportunistic screening for Chlamydia trachomatis (CT) ...
To estimate the cost-effectiveness of a systematic one-off Chlamydia trachomatis (CT) screening prog...
Chlamydia trachomatis is the most prevalent sexually transmitted bacteria in the US and results in r...
Objective. To estimate the cost effectiveness of Chlamydia trachomatis (CT) screening of young women...
OBJECTIVE: To assess the cost-effectiveness of pharmacotherapy for male partners in screening women ...
BACKGROUND: The majority of Chlamydia trachomatis infections in women are asymptomatic, but may give...